Insider · CIK 0001838539
Eugene Schneider
Files at IONS (IONIS PHARMACEUTICALS INC). First filing Jan 17, 2025, latest Jun 30, 2026.
In brief
Eugene Schneider files SEC Form 4 as officer at IONS (IONIS PHARMACEUTICALS INC). Since Jan 17, 2025, Eugene Schneider has reported 0 open-market buys worth $0 and 8 open-market sells worth $5.6M, the latest filed on Jun 30, 2026.
A track record needs three past buys with six months of prices behind them; Eugene Schneider has 0, so none is measured yet.
The newest scored trade: sold $2.1M of IONS on Jun 26, 2026, filed Jun 30, 2026, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $3.7M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IONS: IONIS PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | IONIS PHARMACEUTICALS INC | $2.1M 26,000 shares | -25% | +105% from low-6% from high | |
| 26Weak | IONIS PHARMACEUTICALS INC | $412k 5,812 shares | -8% | +180% from low-18% from high | |
| 48Moderate | IONIS PHARMACEUTICALS INC | $516k 6,179 shares | -8% | +224% from low-1% from high | |
| 41Moderate | IONIS PHARMACEUTICALS INC | $703k 9,302 shares | -13% | +199% from low-8% from high | |
| 30Weak | IONIS PHARMACEUTICALS INC | $1.2M 19,658 shares | -28% | +137% from low0% from high | |
| 31Weak | IONIS PHARMACEUTICALS INC | $409k 9,549 shares | -16% | +70% from low-0% from high | |
| 37Weak | IONIS PHARMACEUTICALS INC | $48k 1,484 shares | -2% | - | |
| 32Weak | IONIS PHARMACEUTICALS INC | $214k 6,523 shares | -10% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 26, 2026 | IONS IONIS PHARMACEUTICALS INC | 47,884 0.03% of outstanding | $3.9M | Jun 26, 2026 | none |
| Mar 19, 2026 | IONS IONIS PHARMACEUTICALS INC | 5,812 0.00% of outstanding | $412k | Mar 19, 2026 | $513k |
| Jan 30, 2026 | IONS IONIS PHARMACEUTICALS INC | 6,179 0.00% of outstanding | $513k | Jan 30, 2026 | $703k |
| Jan 16, 2026 | IONS IONIS PHARMACEUTICALS INC | 9,302 0.01% of outstanding | $709k | Jan 16, 2026 | none |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | 19,658 0.01% of outstanding | $1.2M | Sep 3, 2025 | $409k |
| Aug 4, 2025 | IONS IONIS PHARMACEUTICALS INC | 9,549 0.01% of outstanding | $409k | Aug 4, 2025 | none |
| Jan 31, 2025 | IONS IONIS PHARMACEUTICALS INC | 1,700 0.00% of outstanding | $56k | Jan 31, 2025 | $214k |
| Jan 16, 2025 | IONS IONIS PHARMACEUTICALS INC | 6,523 0.00% of outstanding | $213k | Jan 16, 2025 | none |
| Dec 27, 2023 | IONS IONIS PHARMACEUTICALS INC | 25,000 0.02% of outstanding | $1.3M | Dec 26, 2023 | none |
Transactions
Every row this insider has filed, 25 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +26,000 | $60.89 | $1.6M | 103,114 | Jun 30, 2026 |
| Jun 26, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -26,000 | $81.05 | $2.1M | 77,114 | Jun 30, 2026 |
| Jun 26, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -26,000 | $0.00 | $0 | 26,000 | Jun 30, 2026 |
| Mar 19, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -5,812 | $70.97 | $412k | 63,890 | Mar 23, 2026 |
| Jan 29, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Common Stock | +11,991 | $0.00 | $0 | 75,881 | Feb 2, 2026 |
| Jan 30, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -6,179 | $83.45 | $516k | 69,702 | Feb 2, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +21,685 | $0.00 | $0 | 73,192 | Jan 20, 2026 |
| Jan 16, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -9,302 | $75.59 | $703k | 63,890 | Jan 20, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Performance Restricted Stock Unitsderivative | +25,800 | $0.00 | $0 | 91,237 | Jan 20, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -21,685 | $0.00 | $0 | 39,251 | Jan 20, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +9,675 | $0.00 | $0 | 48,926 | Jan 20, 2026 |
| Jan 2, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +19,350 | $0.00 | $0 | 19,350 | Jan 6, 2026 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +19,658 | $53.77 | $1.1M | 71,165 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -12,455 | $60.46 | $753k | 58,710 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -7,203 | $61.42 | $442k | 51,507 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -19,658 | $0.00 | $0 | 0 | Sep 4, 2025 |
| Aug 4, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -9,549 | $42.80 | $409k | 51,507 | Aug 5, 2025 |
| Jan 30, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Common Stock | +4,032 | $0.00 | $0 | 62,540 | Feb 3, 2025 |
| Jan 31, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -1,484 | $32.20 | $48k | 61,056 | Feb 3, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +17,372 | $0.00 | $0 | 65,031 | Jan 17, 2025 |
| Jan 16, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -6,523 | $32.79 | $214k | 58,508 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Performance Restricted Stock Unitsderivative | +22,000 | $0.00 | $0 | 65,437 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +33,000 | $0.00 | $0 | 78,308 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -17,372 | $0.00 | $0 | 60,936 | Jan 17, 2025 |
| Jan 2, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Jan 6, 2025 |
Questions about Eugene Schneider
Answered from the filings on this page, as of the latest one.
Is Eugene Schneider buying or selling?
In the last 12 months Eugene Schneider reported 0 open-market buys worth $0 and 4 open-market sells worth $3.7M on SEC Form 4; the latest was sold $2.1M of IONS on Jun 26, 2026. Grants, option exercises and tax withholding are not counted.
How did Eugene Schneider's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eugene Schneider has 0.
Where does Eugene Schneider file Form 4?
Eugene Schneider has filed Form 4 at IONS (IONIS PHARMACEUTICALS INC) as EVP, Chf Clinical Develop Ofcr. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.